- Home
- ATHA vs STAI Comparison
ATHA vs STAI Comparison
Compare ATHA & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- STAI
- Stock Information
- Founded
- ATHA 2011
- STAI 2011
- Country
- ATHA United States
- STAI United States
- Employees
- ATHA N/A
- STAI N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- STAI
- Sector
- ATHA Health Care
- STAI
- Exchange
- ATHA Nasdaq
- STAI Nasdaq
- Market Cap
- ATHA 15.7M
- STAI 16.4M
- IPO Year
- ATHA 2020
- STAI N/A
- Fundamental
- Price
- ATHA $0.37
- STAI $0.58
- Analyst Decision
- ATHA Buy
- STAI
- Analyst Count
- ATHA 4
- STAI 0
- Target Price
- ATHA $11.25
- STAI N/A
- AVG Volume (30 Days)
- ATHA 293.7K
- STAI 19.6M
- Earning Date
- ATHA 08-12-2025
- STAI 01-01-0001
- Dividend Yield
- ATHA N/A
- STAI N/A
- EPS Growth
- ATHA N/A
- STAI N/A
- EPS
- ATHA N/A
- STAI N/A
- Revenue
- ATHA N/A
- STAI $907,637.00
- Revenue This Year
- ATHA N/A
- STAI N/A
- Revenue Next Year
- ATHA N/A
- STAI N/A
- P/E Ratio
- ATHA N/A
- STAI N/A
- Revenue Growth
- ATHA N/A
- STAI 247.64
- 52 Week Low
- ATHA $0.22
- STAI $0.56
- 52 Week High
- ATHA $3.67
- STAI $9.07
- Technical
- Relative Strength Index (RSI)
- ATHA 47.14
- STAI N/A
- Support Level
- ATHA $0.34
- STAI N/A
- Resistance Level
- ATHA $0.51
- STAI N/A
- Average True Range (ATR)
- ATHA 0.05
- STAI 0.00
- MACD
- ATHA -0.01
- STAI 0.00
- Stochastic Oscillator
- ATHA 25.41
- STAI 0.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About STAI ScanTech AI Systems Inc. Common stock
ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.